Roberto Alcántara Selected Research

Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)

6/2022

Identifying RO9021 as a Potential Inhibitor of PknG from Mycobacterium tuberculosis: Combinative Computational and In Vitro Studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roberto Alcántara Research Topics

Disease

4	Multiple Organ Failure (MODS) 12/2022 - 01/2019
3	Tuberculosis (Tuberculoses) 01/2021 - 01/2019
1	Latent Infection 06/2022

Drug/Important Bio-Agent (IBA)

3	Pyrazinamide FDA LinkGeneric 01/2021 - 01/2019
2	Culture MediaIBA 12/2022 - 01/2022
2	PowdersIBA 12/2022 - 01/2022
2	pyrazinoic acidIBA 01/2021 - 01/2019
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 06/2022
1	AcidsIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2020
1	ammonium ferrous sulfateIBA 01/2019